Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 7, 2013

Agenus, Bayer, Celgene, Galderma, Genentech, NovaBay, Omeros, Regeneron, Roche

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I Omeros TMA treatment well tolerated . . . read more Phase II Agenus posts good herpes vax results . . . read more NovaBay impetigo treatment misses endpoint . . . read more Phase III Celgene to present Revlimid data at ASH . . . read more Gazyva wallops Rituxan in CLL trial . . . read more Filings Bayer files for DME indication for Eylea . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters